For example, the anti-tumor effect of TMZ with ATMi or PARPi is enhanced in IDH1 mutant gliomas, and TMZ increases ATRi sensitivity in MGMT-deficient GB cells [35,36,37]. Here, IDH1 is linked to central nervous system cancer.